Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI
Molekulargewicht:
1322
CAS Nummer:
[679809-58-6]
Formel:
C42H59N3Na4O35S2
Target-Kategorie:
Thrombin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten